Individuals
Businesses
Company
Intelligence
News
African Capital Markets
EnglishEnglish
share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram

Egyptian B2B healthtech i'SUPPLY closes pre-Series A round

Daba Finance/Egyptian B2B medtech i'SUPPLY closes pre-Series A round
STARTUP VENTURE CAPITALJune 11, 2024 at 10:59 PM UTC

TLDR

  • Egypt-based B2B healthtech company i‘SUPPLY secures pre-Series A round, bringing total funding to $2.5 million.
  • Investments from Disruptech Ventures, OneStop Capital, Axian Investment CVC, Egypt Ventures, among others.
  • i‘SUPPLY aims to digitize pharmaceutical business through supply chain management and expansion plans.

Egypt-based B2B healthtech company i‘SUPPLY has secured a pre-Series A round, bringing its total funding to $2.5 million since its inception in 2022. The round included investments from Disruptech Ventures, OneStop Capital, Axian Investment CVC, and Egypt Ventures, among others.

Founded in 2022 by Ibrahim Emam, Malek Sultan, and Moustafa Zaki, i‘SUPPLY aims to digitize the pharmaceutical business with a one-stop-shop solution to predict and manage supply chain disruptions.

The new funding will support i’SUPPLY’s expansion plans, enhance financing for small and medium-sized pharmacies, and advance its fintech and technological services. In 2022, i‘SUPPLY raised a $1.5 million pre-seed round, led by Disruptech Ventures.

Key Takeaways

There is a significant opportunity for startups aiming to improve the healthcare supply chain in Africa, particularly in Egypt. The North African nation's pharmaceutical industry is projected to generate $1.45 million in revenue in 2024, with a compound annual growth rate (CAGR) of 7.68% from 2024 to 2028, leading to a market volume of $1.948 million by 2028. Simultaneously, Egypt's digital health market is anticipated to expand from $0.59 billion in 2022 to $2.56 billion by 2030, growing at a CAGR of 20.1% between 2022 and 2030. This growth presents a robust market for innovative solutions in the healthcare supply chain, particularly those that leverage digital technologies to enhance efficiency and reliability.

Egypt
Healthcare
Healthtech
i’SUPPLY
Disruptech Ventures
OneStop Capital
Axian Investment CVC
Egypt Ventures
Venture Capital
Startups
Venture Funding

Think someone else should see this?

share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram
Stay informed with our newsletters read by 25,000+ professionals worldwide
Newsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companies

Next Frontier

Stay up to date on major news and events in African markets. Delivered weekly.

Pulse54

UDeep-dives into what’s old and new in Africa’s investment landscape. Delivered twice monthly.

Events

Sign up to stay informed about our regular webinars, product launches, and exhibitions.

+25k investors have already subscribed

To invest in this opportunity and other opportunities across Africa

Download the daba finance app on your mobile through
appstore iconappstore icon
Phone Image

Take action.

Download app

Start investing in Africa’s best opportunities, including stocks, bonds, startups, venture funds, and more.

Partner with us

Unlock exciting business opportunities and growth potential.

Join Daba

Become a part of our vibrant community and enjoy exclusive benefits.

Contact us

Reach out to us for inquiries, support, or collaboration.
For Investor
StrategiesPortfolio ManagementAfrican Capital MarketsNews
Daba Pro Intelligence
For Capital Seekers
For StartupsFor Fund ManagersFor Private CompaniesFor Lenders
For Partners
Commercial BanksBroker DealersAsset ManagersInvestment BanksInvestment Advisors and ConsultantsLenders and Microfinance
Company
About UsMarket UpdatesEventsBlog and PodcastNewsletterCase StudiesAffiliate ProgramInvesting GlossaryOfficial ContactsTrust, Compliance and SecurityFrequently Asked Questions

Terms & ConditionsPrivacy Policy
EnglishEnglish

Owned by Daba Markets Inc. By using this site, you accept our Terms and Conditions and Privacy Policy. © 2024 All rights reserved. 2025 All rights reserved